Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q2 FY24 results · Jul–Sep 2023
Dr. Lal Path Labs reported revenue from operations of ₹601.30 crore (up 12.6% from Q2 FY23) and net profit of ₹110.70 crore (up 52.9% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 601.30 | 533.80 | +12.6% | 541.00 | +11.1% |
| Other income | 18.10 | 8.70 | +108.0% | 14.40 | +25.7% |
| Total income | 619.40 | 542.50 | +14.2% | 555.40 | +11.5% |
| Profit before tax | 152.20 | 102.80 | +48.1% | 117.50 | +29.5% |
| Net profit for the period | 110.70 | 72.40 | +52.9% | 83.60 | +32.4% |
| Attributable to shareholders of the company | 109.30 | 71.70 | +52.4% | 82.60 | +32.3% |
| EPS, basic (₹) | 13.16 | 8.64 | +52.3% | 9.95 | +32.3% |
| Net margin (%) | 18.4 | 13.6 | 15.5 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 531.70 | 466.90 | +13.9% | 480.10 | +10.7% |
| Other income | 14.10 | 7.60 | +85.5% | 15.00 | −6.0% |
| Total income | 545.80 | 474.50 | +15.0% | 495.10 | +10.2% |
| Profit before tax | 150.90 | 106.40 | +41.8% | 125.10 | +20.6% |
| Net profit for the period | 113.00 | 78.60 | +43.8% | 93.60 | +20.7% |
| EPS, basic (₹) | 13.60 | 9.50 | +43.2% | 11.28 | +20.6% |
| Net margin (%) | 21.3 | 16.8 | 19.5 |
Consolidated
- Filed with BSE
- 03 Nov 2023, 13:22 IST
- Board meeting
- 02 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Nov 2023, 13:22 IST
- Board meeting
- 02 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE